Pharmacopeia has earned a milestone payment as part of its discovery collaboration with Celgene Corp., marking the completion of Pharmacopeia’s obligations under the terms of the companies’ agreement. Pharmacopeia is entitled to receive further milestone payments if collaboration programs progress into and through clinical development and royalty revenue if products are marketed. “We are pleased with the success that we have achieved in collaboration with Celgene and are c...